The publication “BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells” is on the cover of Blood Journal.
Categories: Article
Article
In J Exp Clin Cancer Res: Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer
Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer Chiara Naro, Ambra Antonioni, Vanessa Medici, Cinzia Caggiano, Ariane Jolly, Pierre de la Grange, Pamela Bielli, Maria Paola Paronetto, Claudio Sette Read more…